Med Sotalol Tablet 80 mg Oral Medican Pharma Incorporated 1998-02-05 2011-03-29 Med Sotalol Tablet 160 mg Oral Medican Pharma Incorporated 1998-02-05 2011-03-29 Mylan-sotalol Tablet 160 mg Oral Mylan Pharmaceuticals 1996-10-21 2017-01-11 Mylan-sotalol Tablet 80 mg Oral Mylan Pharmaceuti...
Left ventricular dysfunction after myocardial infarction is associated with an increased risk of death. Other studies have suggested that a potassium-channel blocker might reduce this risk with minimal adverse effects. We investigated whether d-sotalol, a pure potassium-channel blocker with no clinically...
(1969). HPLC determn in body fluids: W. P. Gluthet al.,Arzneim.-Forsch.38,408 (1988). Review of pharmacology and therapeutic use: B. N. Singhet al.,Drugs34,311-349 (1987); S. H. Hohnloser, R. L. Woosley,N. Engl. J. Med.331,31-38 (1994). Comprehensive description: R. ...
University Hospital, Department of Cardiology, Freiburg, Germany Abstract Background: Polymorphic ventricular tachycardia of the torsade de pointes type represents, potentially, the most dangerous side effect of antiarrhythmic drugs that prolong ventricular repolarization. Much effort has been devoted to the...
Comparison of the long-term efficacy of implantable defibrillators and sotalol for documented spontaneous sustained ventricular tachyarrhythmias secondary to coronary artery disease[J].Aust NZJ Med,1999,29(3):331~341.Comparison of the long-termefficacy of implantable defibrillators and sotalol for ...
Overdrive pacing as treatment of sotalol-induced ventricular tachyarrhythmias (torsade de pointes). Acta Med Scand (Suppl) 1982, 668: 28 -- 33.Totterman KM, Pellinen T. Overdrive pacing as treatment of sotalol-induced ventricular tachyarrhthmias (torsades de pointes). Acta Medica Scandinavica ...
Min/Med/Max, Means ± SD, * p ˂ 0.05, at least, vs. control. 2.2. A Perilous Syndrome Occurred Peripherally 2.2.1. Heart Lung, Liver, Kidney, and Gastrointestinal Lesions Indicatively for a common clue that might be failed (i.e., intracranial (superior sagittal sinus), portal, ...